Psychotropic Medication Advisory Committee

Warning!

It seems that JavaScript is not working in your browser. It could be because it is not supported, or that JavaScript is intentionally disabled. Some of the features on CT.gov will not function properly with out javascript enabled.

Settings Menu

Language
High Contrast
High Contrast Mode On or Off switch
Font Size
Disclaimer

COVID-19: Get the latest updates on COVID-19 at ct.gov/coronavirus. Find a vaccination site near you at ct.gov/covidvaccine.

Have a question concerning the Coronavirus and the Connecticut DCF? E-Mail us: DCF.COVID-19@ct.gov

Psychotropic Medication Advisory Committee (PMAC)

PMAC E-Mail: getmeds.dcf@ct.gov

The FDA Warns Against the Use of Many Genetic Tests with Unapproved Claims to Predict Patient Response to Specific Medications: FDA Safety Communication

2021 Minutes

   May
   March
   February

2020 Minutes

December
November
October
September
July
June 26, 2020
June 5, 2020
May
April
March
February
January

2019 Minutes

December
November
October
September
May
April
March
February
January

Archived Meeting Minutes

DCF and PMAC position paper on supplements edited 9619

Connecticut State Department of Children and Families

Psychotropic Medication Advisory Committee (PMAC)